Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease

QR Code

Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease

Aim. To assess the quality of life of patients with stable coronary heart disease (CHD) initially and 12 months after drug and non-drug secondary prophylaxis according to clinical guidelines.Material and methods. 73 patients (57 men, 16 women) with confirmed stable coronary artery disease were inclu...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. D. Zharkova, Yu. V. Lukina, N. P. Kutishenko, E. T. Huseynova, N. P. Zolotareva, S. Yu. Martsevich, O. M. Drapkina
Format:	Article
Language:	English
Published:	Столичная издательская компания 2023-05-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	stable coronary heart disease quality of life clinical recommendations secondary prevention optimal drug therapy
Online Access:	https://www.rpcardio.online/jour/article/view/2902
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The quality of received drug therapy in patients with stable coronary heart disease according to the ALIGN (TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes) study
by: E. D. Zharkova, et al.
Published: (2022-10-01)

Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study
by: E. D. Zharkova, et al.
Published: (2022-07-01)

An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results
by: S. Yu. Martsevich, et al.
Published: (2020-03-01)

Secondary prevention effectiveness in patients with stable angina
by: Rasim Kutlu, et al.
Published: (2010-08-01)

Implementing principles of coronary heart disease secondary prevention into real-world clinical practice
by: D. M. Aronov, et al.
Published: (2007-02-01)

Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic
by: S. Y. Martsevich, et al.
Published: (2021-03-01)

Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
by: M. G. Bubnova
Published: (2009-08-01)

Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies
by: Yu. V. Lukina, et al.
Published: (2019-11-01)

Coronary Artery Disease with a High Risk of Complications: How to Identify Such Patients and Choose Management Tactics?
by: S. G. Kanorskii
Published: (2020-07-01)

Secondary prevention of coronary heart disease in Moscow-population patients with myocardial infarction
by: R. G. Oganov, et al.
Published: (2005-06-01)

Untapped Possibilities of Antiischemic Therapy after Acute Myocardial Infarction: Data from the PROFILE-IM Register
by: E. P. Kalaydzhyan, et al.
Published: (2020-11-01)

Methods for improving of secondary cardiovascular prevention in patients after acute coronary syndrome
by: S. P. Podolnaya, et al.
Published: (2021-06-01)

Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)
by: M. G. Bubnova, et al.
Published: (2010-12-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)
by: S. В. Fitilev, et al.
Published: (2018-05-01)

Prediction of clinical course in patients with diffuse coronary artery disease after coronary bypass surgery
by: S. K. Kurbanov, et al.
Published: (2022-02-01)

Long-term effectiveness of secondary prevention in patients with acute coronary syndrome
by: I. B. Ryzhikova, et al.
Published: (1970-01-01)

Cardiovascular risk stratification in stable coronary artery disease based on prognostic scores and models
by: S. N. Tolpygina, et al.
Published: (2020-07-01)

The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease
by: G. N. Soboleva, et al.
Published: (2020-05-01)

CORONARY ATHEROSCLEROSIS FACTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND METABOLIC SYNDROME
by: T. V. Krovyakova, et al.
Published: (2010-06-01)

Causes of paroxysmal dyspnea in patients with stable coronary artery disease
by: S. F. Yarmedova, et al.
Published: (2024-06-01)

Myocardial ischemia as a cause of paroxysmal dyspnea in patients with stable coronary artery disease
by: S. F. Yarmedova, et al.
Published: (2025-02-01)

Angiographic equivalents of stable angina in patients with coronary atherosclerosis and myocardial infarction
by: A. I. Koryakov
Published: (2005-10-01)

Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey
by: N. V. Pogosova, et al.
Published: (2020-12-01)

Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation)
by: L. A. Khaisheva, et al.
Published: (2019-01-01)

Modern principles of pharmaceutical treatment in patients with chronic coronary heart disease
by: S. Yu. Martsevich
Published: (2008-06-01)

LIFE QUALITY ASSESSMENT OF PATIENTS WITH STABLE CORONARY ARTERY DISEASE AFTER MYOCARDIAL REVASCULARIZATION
by: I. A. Narkevich, et al.
Published: (2021-05-01)

CYTOPROTECTOR MILDRONATE IN CORRECTING MYOCARDIAL DYSFUNCTION AMONG STABLE ANGINA PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-04-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

Changes in Long-term Mortality in Patients with Myocardial Infarction History According to the LIS Luberetskiy registry
by: S. Y. Martsevich, et al.
Published: (2022-05-01)

Comparative analysis of a survey of outand inpatient physicians on secondary prevention of noncommunicable diseases
by: M. N. Mamedov, et al.
Published: (2025-07-01)

Stress echocardiography vs coronary oomputed tomography angiography for the detection of obstructive coronary artery disease in patients aged >70 years with suspected stable coronary artery disease
by: S. G. Kozlov, et al.
Published: (2020-11-01)

Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
by: Yu. A. Karpov, et al.
Published: (2021-09-01)

Causes of shortness of breath in patients with stable coronary heart disease
by: S. F. Yarmedova, et al.
Published: (2022-10-01)

Effects of Pharmacy Care Program on medication adherence in outpatients with stable coronary artery disease: a randomized controlled study
by: S. B. Fitilev, et al.
Published: (2022-01-01)

Diagnostic significance of myocardial and multimodal contrast exercise stress echocardiography in the detection of hemodynamically significant coronary artery stenosis in stable angina pectoris
by: S. N. Koretsky, et al.
Published: (2023-05-01)

THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY
by: S. Yu. Martsevich, et al.
Published: (2017-01-01)

THE ROLE OF PULSE REDUCTION THERAPY IN ADDITIONAL IMPROVEMENT OF CLINICAL EFFECTS OF MYOCARDIAL REVASCULARIZATION IN CORONARY HEART DISEASE STABLE ANGINA PATIENTS
by: D. M. Aronov, et al.
Published: (2018-06-01)

Arterial hypertension and coronary heart disease treatment compliance – a key factor in cardiovascular mortality reduction
by: G. V. Pogosova, et al.
Published: (2007-02-01)

EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)